New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, Belgium, Italy
Keywords: Health, Medical, Policy, Public Dialogue - health
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.